Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing

The feasibility of rapid genetic testing in patients undergoing percutaneous coronary intervention (PCI) and the comparison of the pharmacodynamic effects of prasugrel versus ticagrelor among carriers of cytochrome P450 2C19 loss-of-function alleles treated with PCI has been poorly explored. Rapid g...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchi, Francesco, Rollini, Fabiana, Rivas, Jose, Rivas, Andrea, Agarwal, Malhar, Briceno, Maryuri, Wali, Mustafa, Nawaz, Ahmed, Silva, Gabriel, Shaikh, Zubair, Maailiki, Naji, Been, Latonya, Pineda, Andres M., Suryadevara, Siva, Soffer, Daniel, Zenni, Martin M., Bass, Theodore A., Angiolillo, Dominick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251226/
https://www.ncbi.nlm.nih.gov/pubmed/32478205
http://dx.doi.org/10.1016/j.jacbts.2020.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251226/
https://www.ncbi.nlm.nih.gov/pubmed/32478205
http://dx.doi.org/10.1016/j.jacbts.2020.02.009

Ejemplares similares